Results for both the TCGA and GSE4290 datasets indicated that elevated SDC1 expression is closely associated with increased progression in glioma tumors; the comparatively low malignancy of Grade II glioma might partially explain the lack of an increase in SDC1 expression in that stage. The gene discussed is SDC1; the disease is glioma.